Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum 9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

GREY:DGCRF - Post Discussion

9342-8530 Quebec Inc > Some thoughts..
View:
Post by Dibah42 on Jan 03, 2016 2:39pm

Some thoughts..

Mulling over things I was wondering what might have caused the change in attitude at HOLX that led to this asset buyout?  Is it possible that San Diego has been working all along to put Progensa on the Panther menu?  And that they are now ready to announce Progensa on the Panther?  Are their cumulative sales of PCA3 approaching $50m where the royalties double to 16%?
Does anyone here know what the cumulative sales figure might be?  Just thinking out loud.
Cheers.
Comment by oceanblvd on Jan 05, 2016 2:04pm
i told yves over a year ago that holx was just waiting for cur to go bankrupt and take over pca3 for nothing before they promote it. you watch how much marketing and profits they make from fradet not knowing how to make a deal caused.somehow it would be nice for his medical career to have the same results as cur .
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities